Meeting Report: The Dallas Consensus Conference on Liver Transplantation for Alcohol Associated Hepatitis

被引:87
|
作者
Asrani, Sumeet K. [1 ]
Trotter, James [1 ]
Lake, Jack [2 ]
Ahmed, Aijaz [3 ]
Bonagura, Anthony [4 ]
Cameron, Andrew [5 ]
DiMartini, Andrea [6 ]
Gonzalez, Stevan [7 ]
Im, Gene [8 ]
Martin, Paul [9 ]
Mathurin, Philippe [10 ]
Mellinger, Jessica [11 ]
Rice, John P. [12 ]
Shah, Vijay H. [13 ]
Terrault, Norah [14 ]
Wall, Anji [1 ]
Winder, Scott [11 ]
Klintmalm, Goran [1 ]
机构
[1] Baylor Univ, Med Ctr, 3410 Worth St,Suite 860, Dallas, TX 75246 USA
[2] Univ Minnesota, Minneapolis, MN USA
[3] Stanford Univ, Stanford, CA 94305 USA
[4] Optum, Philadelphia, PA USA
[5] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[6] Univ Pittsburgh, Pittsburgh, PA USA
[7] Baylor All St Med Ctr, Ft Worth, TX USA
[8] Mt Sinai Hosp, New York, NY 10029 USA
[9] Univ Miami Hlth Syst, Miami, FL USA
[10] Hop Claude Huriez, Serv Hepatogastroenterol, Lille, France
[11] Univ Michigan, Ann Arbor, MI 48109 USA
[12] Univ Wisconsin, Madison, WI USA
[13] Mayo Clin, Rochester, MN USA
[14] Univ Southern Calif, Los Angeles, CA 90007 USA
关键词
DISEASE; EPIDEMIOLOGY; ALLOCATION; MORTALITY; SURVIVAL; OUTCOMES; TARGETS; GRAFTS; TRIALS; MODEL;
D O I
10.1002/lt.25681
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Liver transplantation (LT) for alcohol associated hepatitis (AH) remains controversial. We convened a consensus conference to examine various aspects of LT for AH. The goal was not to unequivocally endorse LT for AH; instead, it was to propose recommendations for programs that perform or plan to perform LT for AH. Criteria were established to determine candidacy for LT in the setting of AH and included the following: (1) AH patients presenting for the first time with decompensated liver disease that are nonresponders to medical therapy without severe medical or psychiatric comorbidities; (2) a fixed period of abstinence prior to transplantation is not required; and (3) assessment with a multidisciplinary psychosocial team, including a social worker and an addiction specialist/mental health professional with addiction and transplantation expertise. Supporting factors included lack of repeated unsuccessful attempts at addiction rehabilitation, lack of other substance use/dependency, acceptance of diagnosis/insight with a commitment of the patient/family to sobriety, and formalized agreement to adhere to total alcohol abstinence and counseling. LT should be avoided in AH patients who are likely to spontaneously recover. Short-term and longterm survival comparable to other indications for LT must be achieved. There should not be further disparity in LT either by indication, geography, or other sociodemographic factors. Treatment of alcohol-use disorders should be incorporated into pre- and post-LT care. The restrictive and focused evaluation process described in the initial LT experience for AH worldwide may not endure as this indication gains wider acceptance at more LT programs. Transparency in the selection process is crucial and requires the collection of objective data to assess outcomes and minimize center variation in listing. Oversight of program adherence is important to harmonize listing practices and outcomes.
引用
收藏
页码:127 / 140
页数:14
相关论文
共 50 条
  • [31] Advances and innovations in living donor liver transplant techniques, matching and surgical training: Meeting report from the living donor liver transplant consensus conference
    Sturdevant, Mark
    Ganesh, Swaytha
    Samstein, Benjamin C.
    Verna, Elizabeth
    Rodriguez-Davalos, Manuel
    Kumar, Vineeta
    Abouljoud, Marwan
    Andacoglu, Oya
    Askar, Medhat
    Broering, Dieter
    Emamaullee, Juliet C.
    Emond, Jean E.
    Haugen, Christine T.
    Jesse, Michelle
    Kasahara, Mureo
    Liapakis, AnnMarie
    Mandelbrot, Didier
    Pillai, Anjana R.
    Roll, Garrett
    Selzner, Nazia
    Emre, Sukru
    CLINICAL TRANSPLANTATION, 2023, 37 (07)
  • [32] Meeting Report: Consensus Recommendations for a Research Agenda in Exercise in Solid Organ Transplantation
    Mathur, S.
    Janaudis-Ferreira, T.
    Wickerson, L.
    Singer, L. G.
    Patcai, J.
    Rozenberg, D.
    Blydt-Hansen, T.
    Hartmann, E. L.
    Haykowsky, M.
    Helm, D.
    High, K.
    Howes, N.
    Kamath, B. M.
    Lands, L.
    Marzolini, S.
    Sonnenday, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (10) : 2235 - 2245
  • [33] Granulocyte-colony stimulating factor use in alcohol-associated hepatitis: is it time to promote liver regeneration?
    Diaz, Luis Antonio
    Arab, Juan Pablo
    Leggio, Lorenzo
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2024, 50 (02): : 128 - 131
  • [34] Report from a consensus conference on primary graft dysfunction after cardiac transplantation
    Kobashigawa, Jon
    Zuckermann, Andreas
    Macdonald, Peter
    Leprince, Pascal
    Esmailian, Fardad
    Luu, Minh
    Mancini, Donna
    Patel, Jignesh
    Razi, Rabia
    Reichenspurner, Hermann
    Russell, Stuart
    Segovia, Javier
    Smedira, Nicolas
    Stehlik, Josef
    Wagner, Florian
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : 327 - 340
  • [35] Report from a consensus conference on antibody-mediated rejection in heart transplantation
    Kobashigawa, Jon
    Crespo-Leiro, Maria G.
    Ensminger, Stephan M.
    Reichenspurner, Hermann
    Angelini, Annalisa
    Berry, Gerald
    Burke, Margaret
    Czer, Lawrence
    Hiemann, Nicola
    Kfoury, Abdallah G.
    Mancini, Donna
    Mohacsi, Paul
    Patel, Jignesh
    Pereira, Naveen
    Platt, Jeffrey L.
    Reed, Elaine F.
    Reinsmoen, Nancy
    Rodriguez, E. Rene
    Rose, Marlene L.
    Russell, Stuart D.
    Starling, Randy
    Suciu-Foca, Nicole
    Tallaj, Jose
    Taylor, David O.
    Van Bakel, Adrian
    West, Lori
    Zeevi, Adriana
    Zuckermann, Andreas
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (03): : 252 - 269
  • [36] Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis
    Lee, Brian P.
    Samur, Sumeyye
    Dalgic, Ozden O.
    Bethea, Emily D.
    Lucey, Michael R.
    Weinberg, Ethan
    Hsu, Christine
    Rinella, Mary E.
    Im, Gene Y.
    Fix, Oren K.
    Therapondos, George
    Han, Hyosun
    Victor, David W.
    Voigt, Michael D.
    Eswaran, Sheila
    Terrault, Norah A.
    Chhatwal, Jagpreet
    GASTROENTEROLOGY, 2019, 157 (02) : 472 - +
  • [37] Multicentered study of patient outcomes after declined for early liver transplantation in severe alcohol-associated hepatitis
    Hsu, Christine C.
    Dodge, Jennifer L.
    Weinberg, Ethan
    Im, Gene
    Ko, Jimin
    Davis, William
    Rutledge, Stephanie
    Dukewich, Matthew
    Shoreibah, Mohamed
    Aryan, Mahmoud
    Vosooghi, Aidan
    Lucey, Michael
    Rice, John
    Terrault, Norah A.
    Lee, Brian P.
    HEPATOLOGY, 2023, 77 (04) : 1253 - 1262
  • [38] Outcomes after liver transplantation for combined alcohol and hepatitis C virus infection
    Rashid Khan
    Ashwani K Singal
    Bhupinderjit S Anand
    World Journal of Gastroenterology, 2014, (34) : 11935 - 11938
  • [39] Approaching Alcohol Use Disorder After Liver Transplantation for Acute Alcoholic Hepatitis
    Ting, Peng-Sheng
    Gurakar, Ahmet
    Wheatley, Jason
    Chander, Geetanjali
    Cameron, Andrew M.
    Chen, Po-Hung
    CLINICS IN LIVER DISEASE, 2021, 25 (03) : 645 - 671
  • [40] Donor Warm Ischemia Time in DCD Liver Transplantation-Working Group Report From the ILTS DCD, Liver Preservation, and Machine Perfusion Consensus Conference
    Kalisvaart, Marit
    Croome, Kristopher P.
    Hernandez-Alejandro, Roberto
    Pirenne, Jacques
    Cortes-Cerisuelo, Miriam
    Minambres, Eduardo
    Abt, Peter L.
    TRANSPLANTATION, 2021, 105 (06) : 1156 - 1164